News archive

Berlin: Research funding for gender research

Wednesday, 05 April 2023 11:01

A junior research group led by Dr. Claudia Crocini of the Max Rubner Center (MRC) for Cardiovascular-Metabolic-Renal Research at Charité Berlin will investigate gender-specific differences in human heart cells over the next six years.

Microbiologist Prof. Dr. Außerlechner from the Medical University of Innsbruck has received the State Prize for the Promotion of Alternative Methods to Animal Testing 2022 from the State of Austria. He receives the prize for his development of a 3D-printed brain tumor model as an alternative to animal testing.

If the mother suffers an infection during pregnancy, this could possibly promote autism in the child.

The European Partnership for Alternative Approaches to Animal Testing (EPAA) is offering support for students and young scientists with outstanding work in alternative approaches to attend one of two conferences.

The 24th Congress of the International Society for Aerosols in Medicine (ISAM) will be held Aug. 26-30, 2023, in Saarbrücken, Germany. The conference will focus on drug delivery in pulmonary medicine. It will bring together leading scientists in aerosol and drug therapy from academia, industry, hospitals, regulatory agencies, and other healthcare professionals.

Animal-free methods can measure whether a chemical irreversibly damages the eye or does not damage it. However, until now it was not possible to reliably distinguish between irreversible and reversible damage to the eye. Researchers at the Fraunhofer Institute ISC are taking steps to remedy this situation.

This year, Berlin Animal Welfare Prizes will again be awarded. Berlin's State Animal Welfare Officer Dr. Kathrin Herrmann is asking Berliners for suggestions.

Using lung cell culture experiments, scientists at ETH Zurich led by Prof. Shana Sturla have shown which DNA units are altered by benzo(a)pyrene metabolites and where, and thus can trigger lung cancer in the long term.

The Hertie Institute for Artificial Intelligence in Brain Health (Hertie AI), which was founded on February 1 at the Medical Faculty of the University of Tübingen, is the first institute in Germany to conduct research into the prevention and early diagnosis of diseases of the nervous system using methods of artificial intelligence.

Among the ten funded projects, some human 3D models and in silico methods will also be funded.